AstraZeneca joins “TrumpRx” program under new deal to cut Medicaid drug costs
President Trump announces a new deal with AstraZeneca to provide discounted drug prices to U.S. patients. The company will offer reduced prices for specific medications and join the “TrumpRx” website. This development is part of the Trump administration’s effort to make medications more affordable for Americans.